Evidence map›Paper›PMID 35435609›Full record

ReviewMetabolic brain disease2022

Circular RNA: A novel and potential regulator in pathophysiology of schizophrenia.

Mandakini Singh, Sushree Lipsa Lopamudra Dwibedy, Smruti Rekha Biswal, Srinivasan Muthuswamy, Ajay Kumar, Santosh Kumar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Metabolic brain disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Research progress on circular RNA vaccines.Frontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mandakini Singh *Department of Life Science, National Institute of Technology (NIT) Rourkela, Odisha, 769008, India.
Sushree Lipsa Lopamudra Dwibedy *Department of Life Science, National Institute of Technology (NIT) Rourkela, Odisha, 769008, India.
Smruti Rekha BiswalDepartment of Life Science, National Institute of Technology (NIT) Rourkela, Odisha, 769008, India.
Srinivasan MuthuswamyDepartment of Life Science, National Institute of Technology (NIT) Rourkela, Odisha, 769008, India.
Ajay KumarDepartment of Zoology, Institute of Science, Banaras Hindu University, Uttar Pradesh, Varanasi, 221005, India.
Santosh KumarDepartment of Life Science, National Institute of Technology (NIT) Rourkela, Odisha, 769008, India. kumarsantosh@nitrkl.ac.in.ORCID http://orcid.org/0000-0002-3594-4795
National Institute of Technology Rourkela · INBanaras Hindu University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (CircRNAs) are a sub-class of non-coding RNA, which are covalently closed at the ends through a non-canonical process called, backsplicing from the precursor linear RNAs. These molecules are involved in several biological phenomena including regulation of gene expression, synaptic plasticity, and cognition. Several studies have shown that circRNA are present abundantly inside the mammalian brain and they are believed to be associated with the development of neurons and neuronal functions. It is also evident that alterations in intracellular and extracellular levels of circRNAs are linked with various neurological and neuropsychiatric disorders including schizophrenia (SZ). Detailed studies of circRNAs are required to decode the molecular mechanism behind the onset of SZ and the related biological activities during disease progression. This can help unravel their role in this neurobehavioral disorder and develop effective therapeutics against the disease. The present review mainly focuses on the expression and activities of the circRNAs in the post-mortem brain, peripheral blood, and exosomes. It also gives an insight into the role of circRNA interaction with RNA binding proteins (RBPs) and nucleotide modification and their therapeutic potential in the context of schizophrenia.

Indexed as

ExosomesSchizophreniaAnimalsBrainMammalsRNARNA, CircularRNARNA, CircularCircular RNAExosomem6A modificationPeripheral bloodPostmortem brainSchizophrenia

Identifiers

PMID35435609
OpenAlexW4223955530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.